Denmark's health regulator suspends AstraZeneca's COVID-19 vaccine for 14 days after reports of blood clots in some patients after vaccination. “We and the Danish Medical Agency must respond to reports of possible serious side effects both in Denmark and in other European countries,” said Soren Briostrom, Director of the Danish Health Authority.. Danish authorities to conduct vaccine research.
Iceland also made a similar decision to suspend the use of this vaccine, according to Voice of America.. Earlier in Austria, the use of the ABV5300 vaccine AstraZeneca was suspended after a thrombosis was found in a vaccinated person.. This man died. On Wednesday, the European Medical Agency said that " The company says patient safety is a priority and points to rigorous clinical trials that the vaccine has undergone. “Patient safety is AstraZeneca's highest priority,” a company spokesperson said.. "